menu

MENU

繁體中文

Contact Us

Menu

Menu

Company

Introduction
Team & Board of Directors
Partners
Investors
Latest News

R&D Pipeline

Overview
Intranasal Vaccines
Asthma Immunotherapy
Respiratory Antiviral Immunotherapy

Company

Introduction

Team & Board of Director

Partners

Investors

Latest News

R&D Pipeline

Overview

Intranasal Vaccines

Asthma Immunotherapy

Respiratory Antiviral Immunotherapy

Contact us

Latest News

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

November 28, 2022

【環球生技月刊】疫情漸退商機未減！ 昱厚、安特羅續拚新冠、流感臨床進度

Press

November 23, 2022

【經濟日報】昱厚鼻噴新冠藥二/三期臨床收治首位病患 明年第2季完成收案

Press

November 23, 2022

【中天新聞網】看好印尼市場！昱厚鼻噴新冠藥二/三期臨床在印尼收治首位病患　預估明年Q2完成收案

Press

November 22, 2022

First Subject Enrolled in Phase II/III Clinical Trial in Indonesia for Investigational New Drug AD17002-SC in COVID-19 Treatment.

Updates

November 7, 2022

【工商時報】藥廠年底取證 拚史上新高

Press